The Top “8” Important Facts for Providers to Know About Their Patients with Inflammatory Bowel Disease in 2021

Program Release: January 15, 2021 Expiration Date: January 15, 2023 Estimated time to complete: 60 Minutes There are no prerequisites for participation Faculty Sean Fine MD, MS Director, Inflammatory Bowel Disease Center Assistant Professor of Medicine and Medical Science Warren Alpert Medical School of Brown University Abbas Rupawala MD Co-Director, Inflammatory Bowel Disease Center Assistant Professor of Medicine and Medical Science Warren Alpert Medical School of Brown University Overview This virtual educational activity will update healthcare providers with evolving care of patients with Inflammatory Bowel Disease (IBD). Some patients with IBD do not receive preventive health as regular patients and the goal of this presentation is to provide up to date practice for care of patients with IBD.

After participating in this activity, the learner should be better able to: 

• Describe the management goals for IBD
• Outline health maintenance for patients with IBD
• Recognize the side effects of medications used to treat IBD
• Comprehend the Impact of COVID-19 on care of patients with IBD

METHOD OF PARTICIPATION AND HOW TO RECEIVE CME CREDIT

• Review the activity objectives, faculty information, and CME information prior to participating in the activity.
• View the presentation
• Complete the quiz with a passing score of 75% or higher, as well as the activity evaluation. You will then have immediate access to claiming credit and obtaining your certificate. 

FACULTY DISCLOSURE

In accordance with the disclosure policy of the Brown University CME Office as well as standards set forth by the Accreditation Council on Continuing Medical Education (ACCME), speakers have been asked to disclose any relevant financial relationship with the manufacturers of any commercial products and/or provider of commercial services discussed in any educational presentation and with any commercial supporters or exhibitors of this activity.

The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation but to identified openly so that the listener may form his/her own opinion. Any potential conflicts of interest have been resolved prior to this presentation.

This activity may include discussion of off-label or investigative drugs uses. Speakers are aware that it is their responsibility to disclose to the audience this information. Individual Faculty Disclosure information may be found in the conference handouts.

Faculty Disclosure/Conflict of Interest

The following speakers and planning committee members have indicated that they have no relevant financial relationships to disclose:

Sean Fine MD, MSAbbas Rupawala MDMaria Sullivan, BS

DISCLAIMER AND PRIVACY POLICY

Privacy Policy: The Office of Continuing Medical Education (CME) and its educational partners protect the privacy of personal and other information regarding participants and educational collaborators. The CME Office maintains its Internet site as an information resource and service for physicians, other health professionals, and the public. The CME Office will keep your personal information confidential when you participate in a CME Internet-based program. CME collects only the information necessary to provide you with the services that you request.

Disclaimer: This educational program is designed to present scientific information and opinion to Health professionals, to stimulate thought, and further investigation.